Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DRIO - US23725P3082 - Common Stock

13.905 USD
+0.08 (+0.62%)
Last: 11/21/2025, 8:23:47 PM
11.97 USD
-1.93 (-13.92%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DRIO. DRIO was compared to 35 industry peers in the Health Care Technology industry. DRIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DRIO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DRIO had negative earnings in the past year.
DRIO had a negative operating cash flow in the past year.
DRIO had negative earnings in each of the past 5 years.
DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of DRIO (-39.18%) is worse than 68.57% of its industry peers.
Looking at the Return On Equity, with a value of -66.33%, DRIO is doing worse than 68.57% of the companies in the same industry.
Industry RankSector Rank
ROA -39.18%
ROE -66.33%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

DRIO has a Gross Margin (54.98%) which is in line with its industry peers.
DRIO's Gross Margin has improved in the last couple of years.
DRIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DRIO has been increased compared to 1 year ago.
The number of shares outstanding for DRIO has been increased compared to 5 years ago.
DRIO has a better debt/assets ratio than last year.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -5.59, we must say that DRIO is in the distress zone and has some risk of bankruptcy.
DRIO has a worse Altman-Z score (-5.59) than 77.14% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that DRIO is not too dependend on debt financing.
DRIO's Debt to Equity ratio of 0.48 is on the low side compared to the rest of the industry. DRIO is outperformed by 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -5.59
ROIC/WACCN/A
WACC12.2%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

DRIO has a Current Ratio of 3.30. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
DRIO's Current ratio of 3.30 is fine compared to the rest of the industry. DRIO outperforms 77.14% of its industry peers.
A Quick Ratio of 2.83 indicates that DRIO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.83, DRIO is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.83
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.22% over the past year.
Looking at the last year, DRIO shows a very strong growth in Revenue. The Revenue has grown by 32.86%.
DRIO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.03% yearly.
EPS 1Y (TTM)28.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
Revenue 1Y (TTM)32.86%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%

3.2 Future

Based on estimates for the next years, DRIO will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.22% on average per year.
DRIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.06% yearly.
EPS Next Y-215.49%
EPS Next 2Y-7.81%
EPS Next 3Y-7.25%
EPS Next 5Y17.22%
Revenue Next Year-10.78%
Revenue Next 2Y19.42%
Revenue Next 3Y12.32%
Revenue Next 5Y18.06%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -20 -40 -60 -80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as DRIO's earnings are expected to decrease with -7.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.81%
EPS Next 3Y-7.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DRIO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (11/21/2025, 8:23:47 PM)

After market: 11.97 -1.93 (-13.92%)

13.905

+0.08 (+0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners14.64%
Inst Owner Change-88.44%
Ins Owners15.93%
Ins Owner Change5.22%
Market Cap49.36M
Revenue(TTM)27.04M
Net Income(TTM)-42.44M
Analysts82
Price Target20.4 (46.71%)
Short Float %6.78%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.36%
Min EPS beat(2)-17.64%
Max EPS beat(2)24.37%
EPS beat(4)3
Avg EPS beat(4)22.65%
Min EPS beat(4)-17.64%
Max EPS beat(4)73.53%
EPS beat(8)6
Avg EPS beat(8)29.38%
EPS beat(12)9
Avg EPS beat(12)23.21%
EPS beat(16)10
Avg EPS beat(16)17.25%
Revenue beat(2)0
Avg Revenue beat(2)-17.61%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-11.45%
Revenue beat(4)1
Avg Revenue beat(4)-8.98%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-13.89%
Revenue beat(12)4
Avg Revenue beat(12)-8.68%
Revenue beat(16)5
Avg Revenue beat(16)-7.65%
PT rev (1m)-10.11%
PT rev (3m)803.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3873.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-5500%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.24
EYN/A
EPS(NY)-10
Fwd EYN/A
FCF(TTM)-7.58
FCFYN/A
OCF(TTM)-7.55
OCFYN/A
SpS7.65
BVpS18.02
TBVpS-2.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.18%
ROE -66.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.98%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.03%
Cap/Sales 0.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 2.83
Altman-Z -5.59
F-Score4
WACC12.2%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
EPS Next Y-215.49%
EPS Next 2Y-7.81%
EPS Next 3Y-7.25%
EPS Next 5Y17.22%
Revenue 1Y (TTM)32.86%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%
Revenue Next Year-10.78%
Revenue Next 2Y19.42%
Revenue Next 3Y12.32%
Revenue Next 5Y18.06%
EBIT growth 1Y32.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.79%
EBIT Next 3Y25.11%
EBIT Next 5Y16.13%
FCF growth 1Y19.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3YN/A
OCF growth 5YN/A

DARIOHEALTH CORP / DRIO FAQ

What is the fundamental rating for DRIO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DRIO.


What is the valuation status for DRIO stock?

ChartMill assigns a valuation rating of 0 / 10 to DARIOHEALTH CORP (DRIO). This can be considered as Overvalued.


What is the profitability of DRIO stock?

DARIOHEALTH CORP (DRIO) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for DRIO stock?

The Earnings per Share (EPS) of DARIOHEALTH CORP (DRIO) is expected to decline by -215.49% in the next year.